PYXS Insider Transactions
30 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 1–30; provenance stays internal.
PYXS insiders transaction timeline
PurchaseSale
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| Dupont Jakob | Director | 2026-06-30 | Sale | 35,000 | $3.06 |
| HUMPHREY RACHEL | Director | 2025-04-21 | Sale | 13,896.0 | $1.03 |
| HUMPHREY RACHEL | Director | 2025-04-17 | Sale | 200.0 | $0.97 |
| HUMPHREY RACHEL | Director | 2025-04-14 | Sale | 1,400.0 | $0.97 |
| Connealy Pamela Ann | CFO & COO | 2024-11-26 | Purchase | 83,400.0 | $1.96 |
| Connealy Pamela Ann | CFO & COO | 2024-11-26 | Purchase | 5,450.0 | $2.0 |
| Connealy Pamela Ann | CFO and COO | 2023-09-28 | Purchase | 8,000.0 | $1.87 |
| Wadhane Jitendra | Chief Accounting Officer | 2023-09-27 | Purchase | 2,500.0 | $1.87 |
| Connealy Pamela Ann | CFO and COO | 2023-09-27 | Purchase | 6,426.0 | $1.85 |
| Wadhane Jitendra | Chief Accounting Officer | 2023-09-25 | Purchase | 5,000.0 | $1.77 |
| Connealy Pamela Ann | CFO and COO | 2023-09-25 | Purchase | 12,000.0 | $1.67 |
| Wadhane Jitendra | Chief Accounting Officer | 2023-09-22 | Purchase | 2,500.0 | $1.74 |
| Connealy Pamela Ann | CFO and COO | 2023-09-22 | Purchase | 5,000.0 | $1.74 |
| Sullivan Lara | President and CEO | 2023-09-18 | Sale | 8,541.0 | $2.1 |
| Sullivan Lara | President and CEO | 2023-09-14 | Sale | 100.0 | $2.25 |
| Sullivan Lara | President and CEO | 2023-09-13 | Sale | 3,000.0 | $2.27 |
| Sullivan Lara | President and CEO | 2023-09-12 | Sale | 4,917.0 | $2.25 |
| Sullivan Lara | President and CEO | 2023-09-11 | Sale | 20,000.0 | $2.27 |
| PFIZER INC | TenPercentOwner | 2023-03-17 | Purchase | 1,811,594.0 | $2.76 |
| Pfizer Ventures (US) LLC | TenPercentOwner | 2023-03-17 | Purchase | 1,811,594.0 | $2.76 |
| PFIZER INC | TenPercentOwner | 2023-03-17 | Purchase | 1,811,594.0 | $2.76 |
| Pfizer Ventures (US) LLC | TenPercentOwner | 2023-03-17 | Purchase | 1,811,594.0 | $2.76 |
| Chin Mark | Other | 2022-04-21 | Sale | 1,745,761.0 | $3.05 |
| Cline Darren S | Director | 2021-12-08 | Purchase | 10,000.0 | $9.39 |
| Civik Thomas | Director | 2021-11-18 | Purchase | 15,700.0 | $12.74 |
| Cormorant Asset Management, LP | Other | 2021-10-13 | Purchase | 450,000.0 | $16.0 |
| Chen Bihua | DirectorOther | 2021-10-13 | Purchase | 450,000.0 | $16.0 |
| Cormorant Global Healthcare Master Fund, LP | Other | 2021-10-13 | Purchase | 450,000.0 | $16.0 |
| Cormorant Private Healthcare Fund III LP | Other | 2021-10-13 | Purchase | 450,000.0 | $16.0 |
| Chin Mark | Director | 2021-10-13 | Purchase | 312,500.0 | $16.0 |